HB259 Draft Proposed CS ver E.PDF |
HL&C 4/9/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Email Fred Brown 4-6-12.pdf |
HL&C 4/9/2012 3:15:00 PM
|
HB 259
|
HB259 Draft Proposed CS ver D.pdf |
HL&C 4/2/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Charts from Mike Barnhill 3-26-12.pdf |
HL&C 3/26/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-AK Pharm Assoc 3-26-12, Response to the Alaska Teamsters 3-16-12 Memo.pdf |
HL&C 3/26/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Testimony Michael Cartier-Envision Rx Options 3-22-12.pdf |
HL&C 3/26/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Letter-Premera 3-6-12.pdf |
HL&C 3/26/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Testimony by Rose Kalamarides 3-16-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Letter Express Scripts 3-16-12.PDF |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Letter Medco 3-15-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Amendment I.4 with Explanation.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Amendment I.3 with Explanation.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Amendment I.2 with Explanation.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Amendment I.5 with Explanation.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Email Lara Nichols 2-28-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Testimony by Eric Douglas-CVS Caremark 2-27-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Response to Questions- Matthew DiLoreto 2-28-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Letter of Support Richard Holm 2-24-12.pdf |
HL&C 3/16/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Commercial Pharmaceutical Supply Chain flow chart.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Opposing Documents-Testimony by Eric Douglas-CVS Caremark 2-27-12.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Fiscal Note-DHSS-HCMS-2-24-12.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Fiscal Note-DOA-HPA-2-2-12.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Fiscal Note-DCCED-CBPL-02-24-12.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 ver I.PDF |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Model Audit Guidelines for Pharmacy Claims by the Academy of Managed Care Pharmacy, January 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Letter National Community Pharmacists Association, 30 January 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Letter National Association of Chain Drug Stores, 2 February 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Letter Alaska Pharmacists Association, 3 February 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Alaska Pharmacists Association, 84 names of supporters of HB 259.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Examples of State Audit Laws, from Alaska Pharmacists Association, 5 February 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Supporting Documents-Examples of Abusive Auditing Practices in Alaska, from Alaska Pharmacists Association, 10 February 2012.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Sectional Analysis.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|
HB259 Sponsor Statement.pdf |
HL&C 2/27/2012 3:15:00 PM
|
HB 259
|